Immune characterization of pre-clinical murine models of neuroblastoma

Immune characterization of pre-clinical murine models of neuroblastoma

Abstract Immunotherapy offers a potentially less toxic, more tumor-specific treatment for neuroblastoma than conventional cytotoxic therapies. Accurate and reproducible immune competent preclinical models are key to understanding mechanisms of action, interactions with other therapies and mechanisms...

Full description

Bibliographic Details
Main Authors: Emily R. Webb, Silvia Lanati, Carol Wareham, Alistair Easton, Stuart N. Dunn, Tatyana Inzhelevskaya, Freja M. Sadler, Sonya James, Margaret Ashton-Key, Mark S. Cragg, Stephen A. Beers, Juliet C. Gray
Format: Article
Language:English
Published: Nature Portfolio 2020-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-73695-9

Internet

https://doi.org/10.1038/s41598-020-73695-9

Similar Items